News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>CN Biotech Firm Bliss Biopharmaceutical Weighs USD150M HK IPO: Wire
Chinese biotech company Bliss Biopharmaceutical is considering a Hong Kong listing and is working with advisors to potentially raise at least USD150 million, Bloomberg reported.Fou...
Reset
Send
The window will close in 5 seconds
<IPO>CN Biotech Firm Bliss Biopharmaceutical Weighs USD150M HK IPO: Wire
Close
Recommend
9
Positive
12
Negative
4
 
SHORT SELL
 
STOCK INFO

Chinese biotech company Bliss Biopharmaceutical is considering a Hong Kong listing and is working with advisors to potentially raise at least USD150 million, Bloomberg reported.

Founded in 2017 in Hangzhou, Zhejiang Province, Bliss Biopharmaceutical focuses on the research and industrialization of innovative anti-tumor biological drugs.

Related NewsDaiwa Sees Limited Upside for HSI, Prefers HK Stocks w/ Tech Trading Opportunities Like BEIGENE/ Others

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.